Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis

Publisher： Karger

E-ISSN： 1664-5529|2|1|17-26

ISSN： 1664-5529

Source： Nephron Extra, Vol.2, Iss.1, 2012-01, pp. : 17-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mineralocorticoid Receptor Antagonism and Aldosterone Synthesis Inhibition Do Not Improve Glomerulosclerosis and Renal Interstitial Fibrosis in a Model of Chronic Kidney Allograft Injury

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-08 ,pp. : 561-567

Karger

Access to resources Recommend Favorite

The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 20, Iss. 3, 2000-06 ,pp. : 175-179

Karger

Access to resources Recommend Favorite

Mineralocorticoid Receptor Blockade in Chronic Kidney Disease

By  

Blood Purification, Vol. 33, Iss. 1-3, 2012-01 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonism: A Promising Therapeutic Approach to Treat Ischemic AKI

By  

Nephron, Vol. 134, Iss. 1, 2016-03 ,pp. : 10-13

Karger

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety

By  

Blood Purification, Vol. 41, Iss. 1-3, 2016-01 ,pp. : 166-170

Karger

Access to resources Recommend Favorite